Showing results (31-40 of 122) with videos related to
Sort By:
Pageof 13
Lupus|April 28, 2019
Diet and lupus: what do the patients think?G A Robinson, T Mcdonnell, C Wincup, et al.British Journal of Clinical Pharmacology|November 19, 2016
Effect of ketoconazole, a strong CYP3A inhibitor, on the pharmacokinetics of venetoclax, a BCL-2 inhibitor, in patients with non-Hodgkin lymphomaSuresh K Agarwal, Ahmed Hamed Salem, Alexey V Danilov, et al.Analytical Chemistry|July 25, 2008
Pharmacodynamic assessment of histone deacetylase inhibitors: infrared vibrational spectroscopic imaging of protein acetylationTsoching Chen, Min-Jung Lee, Yeong Sang Kim, et al.Lung Cancer (Amsterdam, Netherlands)|October 16, 2021
Phase 1 multicenter study of the HSP90 inhibitor SNX-5422 plus carboplatin and paclitaxel in patients with lung cancersMartin Gutierrez, Robin Guo, Giuseppe Giaccone, et al.Investigative Ophthalmology & Visual Science|August 10, 2022
Dominant Cone Rod Dystrophy, Previously Assigned to a Missense Variant in RIMS1, Is Fully Explained by Co-Inheritance of a Dominant Allele of PROM1Maria Pilar Martin-Gutierrez, Elena R Schiff, Genevieve Wright, et al.Heliyon|May 30, 2023
Combining cell-free RNA with cell-free DNA in liquid biopsy for hematologic and solid tumorsMaher Albitar, Hong Zhang, Ahmad Charifa, et al.Blood|June 19, 2004
Elevated serum-soluble interleukin-2 receptor levels in patients with anaplastic large cell lymphomaJohn E Janik, John C Morris, Stefania Pittaluga, et al.Psycho-Oncology|January 13, 2025
Stress Management Program for Scanxiety in People With Advanced Lung Cancer: Intervention Adaptation and Stakeholder FeedbackHeather Derry-Vick, Amanda Khoudary, Osairys Billini, et al.Iscience|March 4, 2024
Blood metabolomic and transcriptomic signatures stratify patient subgroups in multiple sclerosis according to disease severityAlexandra E Oppong, Leda Coelewij, Georgia Robertson, et al.Gynecologic Oncology|October 10, 2021
An open-label phase I dose-escalation study of the safety and pharmacokinetics of DMUC4064A in patients with platinum-resistant ovarian cancerJoyce Liu, Howard Burris, Judy S Wang, et al.Pageof 13